Research Track

Mini-Symposia

RS01 - Contraception, Pregnancy, and Abortion: Understanding the Family Planning Needs & Experiences of Transgender and Gender-expansive People Assigned Female at Birth in the US

Presenter(s)

• HM

  Heidi Moseson, PhD, MPH

  Epidemiologist / Associate
  Ibis Reproductive Health

  Nothing to disclose

Co-Presenter(s)

• CS

  Cale Stoeffler, BA

  Associate Manager of Patient Services
  Planned Parenthood League of Massachusetts

  Nothing to disclose
• JO

  Juno Obedin-Maliver, MD, MPH, MAS

  Associate Professor
  University of California, San Francisco

  Nothing to disclose
• JH

  Jen Hastings, MD

  Assistant Clinical Professor
  UCSF Department of Family and Community Medicine
  UCSF Department of Family and Community Medicine

  Nothing to disclose
• MD

  Mary Durden, MA

  Policy and Partnerships Manager
  Ibis Reproductive Health

  Nothing to disclose

Transgender and gender expansive (TGE) people face barriers unique to their gender identities that limit access to and may reduce the quality of contraception and abortion care. Discrimination and mis-gendering in the health care setting, among other experiences, deter care-seeking and undermine the bodily autonomy of these patients. Clinicians, researchers, and counselors will share best practices from clinical care, and insights gathered from ongoing nationally-sourced research on gender-inclusive contraception and abortion care in the United States.

Learning Objectives:

• Upon completion, participants will be able to describe respectful, gender and sexuality neutral ways in which to assess risk of unintended pregnancy.
• Upon completion, participants will be able to describe barriers and facilitators to contraception and abortion care experienced by transgender and gender-expansive people in the US.
• Upon completion, participants will be able to list recommendations for improving the quality and accessibility of gender-inclusive sexual and reproductive health care in the US.

1. Upon completion, participants will be able to describe respectful, gender and sexuality neutral ways in which to assess risk of unintended pregnancy.
2. Upon completion, participants will be able to describe barriers and facilitators to contraception and abortion care experienced by transgender and gender-expansive people in the US.
3. Upon completion, participants will be able to list recommendations for improving the quality and accessibility of gender-inclusive sexual and reproductive health care in the US.